Regulatory update: Trametinib US PDUFA date extended to 3 September 2013

GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, its MEK inhibitor, has been extended by 3 months to 3 September 2013.
Source: GSK news - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals